Genesis Therapeutics Company
Genesis Therapeutics unifies AI and biotech to accelerate the discovery of new medicines.
Investors
(Reupload).png)
Technology:
Artificial Intelligence, Biotechnology, Information Technology
Industry:
AI, Early Drug Development, United States
Headquarters:
South San Francisco, California, United States
Founded Date:
2019-11-01
Employees Number:
11-50
Funding Status:
Early Stage Venture
Investors Number:
13
Total Funding:
56100000
Estimated Revenue:
$1M to $10M
Last Funding Date:
2020-12-02
Last Funding Type:
Series A
Register and Claim Ownership